Medicine & Health

Siteman Cancer Center at Barnes-Jewish Hospital and the School of Medicine is launching a prostate cancer screening initiative along with an educational campaign in the St. Louis region to address racial disparities in prostate cancer.

The School of Medicine has received two grants totaling $22.5 million to help lead national efforts to understand how DNA changes create differences in genomes across tissues within the same person.

Repeated mammograms contain data on changes in breast density over time that could help identify women at high risk of breast cancer and even reveal which breast is likely to be affected, according to a study by researchers at the School of Medicine.

Researchers at the School of Medicine have identified four important signs and symptoms that signal an elevated risk of early-onset colorectal cancer. The incidence of colorectal cancer is rising in people under 50, making it important to recognize such signs.

Quing Zhu, at the McKelvey School of Engineering, and Matthew Mutch, MD, at the School of Medicine, have been working together to develop a new imaging technology that can help doctors determine which colorectal cancer patients’ treatments have been successful, helping some to avoid surgery. Their efforts received a $1.75 million National Institutes of Health (NIH) grant.

School of Medicine researchers have received a grant from the National Institutes of Health (NIH) to support training and mentorship for early-career physician-scientists. This funding opportunity will provide support for early-career physicians pursuing careers in cancer research.

Researchers from the laboratory of Amit Pathak at the McKelvey School of Engineering found that cancer cells can sense a layer of cells beneath the top collagen layer on which they normally travel, while normal cells cannot. Their new study was published in Cell Reports.

New research from the School of Medicine suggests that transposable elements in various cancers potentially may be used to harness novel immunotherapies against tumors that don’t typically respond to immune-based treatments.

Daniel C. Link, MD, a highly regarded physician-scientist who treats patients with leukemia and also conducts innovative research, has been named director of the Division of Oncology in the Department of Medicine at the School of Medicine.

Researchers at the School of Medicine have identified a way to sensitize metastatic breast cancer that has spread to bone to immunotherapy.